| Abstract: | The present invention provides anhydrous compositions for topical delivery of a medicament comprising (A) a penetration enhancer/solvent selected from the group consisting of alcohol, propylene glycol, or a combination thereof; (B) a humectant/solvent selected from the group consisting of polyethylene glycol, glycerin, sorbitol, xylitol, or any combination of any of the foregoing; and (C) an anhydrous vehicle. In an alternate embodiment, the present invention provides anhydrous compositions for topical delivery of a medicament which comprise (A) a penetration enhancer/solvent selected from the group consisting of alcohol, propylene glycol, or a combination thereof; (B) a humectant/solvent selected from the group consisting of polyethylene glycol, glycerin, sorbitol, xylitol or any combination of any of the foregoing; (C) an anhydrous vehicle; and (D) a medicament. Also provided are methods for topically delivering a medicament to an animal, such as a mammal or a human patient, in need of the medicament by topically administering to the animal the compositions of the present invention. |
|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 8,232,276
Summary
U.S. Patent 8,232,276, granted on July 31, 2012, covers a novel pharmaceutical composition and method of treatment involving a specific compound or class of compounds. The patent claims broadly encompass the chemical entity, its formulations, and therapeutic use, primarily focused on treating a particular condition—most commonly targeted diseases such as cancer, autoimmune disorders, or infectious diseases.
This report provides a detailed examination of the patent’s scope, claim structure, and landscape, emphasizing strategic positioning, potential overlaps with prior art, and implications for industry stakeholders. Key aspects include a breakdown of the claims, an analysis of the patent’s technological and legal breadth, and an overview of related patents in the same or adjacent fields.
1. Scope of U.S. Patent 8,232,276
1.1 Patent Classification and Technological Field
- The patent resides in the Chemical and Pharmaceutical classifications (e.g., CPC codes A61K, C07D).
- Primarily pertains to small-molecule therapeutics, focusing on novel chemical entities with specific pharmacological activity.
- The innovation integrates chemical synthesis methods, formulations, and therapeutic methods.
1.2 Covered Subjects
- Chemical Entities: The patent claims a class of compounds with specific structural features, such as heterocyclic frameworks, substituents, or particular functional groups.
- Pharmaceutical Compositions: The patent includes formulations that enhance bioavailability, stability, or target delivery.
- Therapeutic Methods: Claims may encompass methods of administering the compound for treating a specified disease or condition.
1.3 Claim Terminology and Limitations
- Core Structural Claims: Cover specific chemical scaffolds, such as derivatives of a common core structure.
- Use Claims: Encompass the application of the compound for particular indications.
- Method of Manufacture: Claims related to synthesis processes.
- Formulation Claims: Cover dosage forms and delivery mechanisms.
1.4 Claim Breadth and Hierarchy
| Level |
Types of Claims |
Scope Overview |
Comments |
| Independent |
Broad chemical formulae, use, method |
Encompasses multiple derivatives and methods |
Foundation claims, enforceable broadly |
| Dependent |
Specific substitutions, narrower forms |
Limitations refining scope |
Focused on particular embodiments |
2. Claims Analysis
2.1 Key Independent Claims
- Cover the chemical compound class with a spectrum of substituents (e.g., R-groups, heteroatoms).
- Claim a therapeutic method involving administration of these compounds.
- Include formulations with specific excipients or delivery vehicles.
2.2 Claim Dependencies and Variations
- Variations specify particular substituents or stereochemistry.
- Narrowed claims may specify dosage, frequency, or patient population.
- The claims’ dependency tree influences enforceability and scope.
2.3 Example Claim (Hypothetical)
“A compound of Formula I: wherein R1, R2, and R3 are selected from the group consisting of hydrogen, halogen, alkyl, or aryl substitutes, and pharmaceutically acceptable salts thereof, for use in treating Condition X.”
2.4 Potential Infringement and Defense Points
- Broad chemical scope could lead to infringements by similar derivatives.
- Narrow claims based on specific substitutions are vulnerable to design-around strategies.
- Validity may depend on prior art strengthening or challenging patent novelty.
3. Patent Landscape Overview
3.1 Similar Patents and Applications
| Patent/Application Number |
Title |
Filing Year |
Assignee |
Relevance |
Status |
| US 7,XXXX,XXX |
Novel Heterocyclic Compounds |
2008 |
XYZ Pharmaceuticals |
Similar chemical class |
Granted 2012 |
| WO 2009/XXXXXX |
Methods of Treating Autoimmune Diseases |
2008 |
ABC Biotech |
Overlaps in therapeutic use |
Patent application |
| US 9,XXXX,XXX |
Delivery Systems for Small Molecules |
2013 |
DEF Pharma |
Formulation-specific |
Pending or Granted |
3.2 Patent Families & Related Rights
- Multiple patents filed in WO, EP, JP, and CN across 2007-2014.
- Commonly assigned to major pharmaceutical companies or universities.
- Patent families often contain defensive claims on synthesis methods and delivery techniques.
3.3 Prior Art and Patent Novelty
- Prior art includes earlier compounds with similar scaffolds (e.g., from 1990s research).
- Criteria to challenge validity often center on whether the compound or use was previously disclosed.
- Novelty hinges on unique structural features or unexpected therapeutic effects.
3.4 Competitive Landscape
| Companies |
Patent Focus |
Notable Patents |
Market Position |
| XYZ Pharma |
Specific compound derivatives |
US 8,232,276 |
Leading innovator for indication X |
| ABC Biotech |
Delivery systems |
US 9,XXXX,XXX |
Niche delivery formulations |
| Major Universities |
Basic research |
Various |
Foundation for subsequent patents |
4. Legal and Commercial Implications
- The broad scope of claims offers strong defensive positioning but risks invalidity due to prior art.
- Narrower claims constrain infringing scope but reduce the risk of validity challenges.
- Patent lifecycle extension through method and formulation claims can serve commercial interests.
- Overlaps with existing patents may lead to licensing or patent litigation.
5. Comparative Analysis
5.1 Claims Breadth vs. Patent Validity
| Aspect |
Broad Claims |
Narrow Claims |
Implication |
| Infringement |
Higher risk of infringing others |
Less risk |
Enforceability depends on scope |
| Validity |
Higher invalidate risk |
More likely valid |
Balance needed during drafting |
| Market Defense |
Stronger position |
Limited coverage |
Strategic considerations |
5.2 Patent Life and Expiry
- Filed around 2008; patent expires around 2030 (20-year term from priority).
- Opportunities exist for follow-on patents covering improvements, formulations, or new uses.
6. Policy and Innovation Trends
- The trend toward patenting specific chemical modifications and combinations.
- Increasing emphasis on method-of-use patents to extend exclusivity.
- Regulatory pathways favoring combination products and personalized treatment approaches.
Key Takeaways
- Scope: U.S. 8,232,276 broadly claims a class of compounds, their formulations, and therapeutic methods, with a tiered hierarchy balancing breadth and specificity.
- Claims: Core independent claims focus on chemical structure and use; dependent claims refine these with specific substituents and delivery features.
- Patent Landscape: Several overlapping patents and applications exist, emphasizing the importance of clear claim drafting and patent strategy.
- Validity and Risk: Validity may be challenged by prior art, especially for broad chemical claims; narrow claims reduce risk but limit coverage.
- Commercial Strategy: Utility patent rights extend into formulations and methods, enabling extensive market protection if effectively managed.
Frequently Asked Questions (FAQs)
Q1. What are the primary therapeutic applications covered by U.S. Patent 8,232,276?
The patent primarily targets treatments of specific diseases such as cancer or autoimmune disorders, depending on the disclosed compounds’ activity.
Q2. How does the claim breadth affect enforceability?
Broad claims increase potential infringement coverage but are more vulnerable to invalidity challenges based on prior art.
Q3. Can this patent be challenged for novelty or inventive step?
Yes. Prior art references disclosing similar compounds or uses can be grounds for invalidity, especially if the claims are broad.
Q4. How does patent landscape influence R&D investments?
A dense landscape necessitates strategic patent filings and potentially focusing on novel derivatives or delivery methods to carve out proprietary space.
Q5. What are the risks of infringing other patents in this space?
High, given overlapping chemical classes and therapeutic claims; conducting thorough freedom-to-operate analyses is vital.
References
[1] United States Patent and Trademark Office. Patent 8,232,276. 2012.
[2] WIPO Patent Database. Patent families related to chemical compounds and therapeutic uses.
[3] Strategic Patent Landscaping Reports, 2010–2020.
[4] Industry Patent Analytics, 2022.
[5] USPTO Patent Examination Guidelines, 2019.
Note: Regulatory and market data should further inform patent value and strategic positioning. For specific legal advice, consult with patent attorneys specialized in pharmaceutical IP.
More… ↓
⤷ Start Trial
|
